{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:55:45Z","timestamp":1790286945006,"version":"4.1.0"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Inborn Errors of Immunity (IEI) comprise more than 450 inherited diseases, from which selected patients manifest a frequent and early incidence of malignancies, mainly lymphoma and leukemia. Primary antibody deficiency (PAD) is the most common form of IEI with the highest proportion of malignant cases. In this review, we aimed to compare the oncologic hallmarks and the molecular defects underlying PAD with other IEI entities to dissect the impact of avoiding immune destruction, genome instability, and mutation, enabling replicative immortality, tumor-promoting inflammation, resisting cell death, sustaining proliferative signaling, evading growth suppressors, deregulating cellular energetics, inducing angiogenesis, and activating invasion and metastasis in these groups of patients. Moreover, some of the most promising approaches that could be clinically tested in both PAD and IEI patients were discussed.<\/jats:p>","DOI":"10.3389\/fimmu.2021.720025","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T06:49:29Z","timestamp":1629182969000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Hallmarks of Cancers: Primary Antibody Deficiency Versus Other Inborn Errors of Immunity"],"prefix":"10.3389","volume":"12","author":[{"given":"Hassan","family":"Abolhassani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Pan-Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00365","article-title":"Cancers Related to Immunodeficiencies: Update and Perspectives","volume":"7","author":"Mortaz","year":"2016","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-00980-1","article-title":"The Ever-Increasing Array of Novel Inborn Errors of Immunity: An Interim Update by the IUIS Committee","volume":"41","author":"Tangye","year":"2021","journal-title":"J Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2011.00098","article-title":"Chronic Inflammation in Cancer Development","volume":"2","author":"Multhoff","year":"2011","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1101\/cshperspect.a026583","article-title":"Spatial Heterogeneity in the Tumor Microenvironment","volume":"6","author":"Yuan","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25726","article-title":"A Catalog of Genetic Syndromes in Childhood Cancer","volume":"62","author":"Zimmerman","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-991","article-title":"Cancer Immunoediting: From Immunosurveillance to Tumor Escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00197","article-title":"Does the Immune System Naturally Protect Against Cancer","volume":"5","author":"Corthay","year":"2014","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in Primary Immunodeficiency Diseases: Cancer Incidence in the United States Immune Deficiency Network Registry","volume":"141","author":"Mayor","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60224","article-title":"MCM4 Mutation Causes Adrenal Failure, Short Stature, and Natural Killer Cell Deficiency in Humans","volume":"122","author":"Hughes","year":"2012","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 Deficiency: A Protean Disorder of Hematopoiesis, Lymphatics, and Immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.147116","article-title":"Non-Hodgkin Lymphoma and Pre-Existing Conditions: Spectrum, Clinical Characteristics and Outcome in 213 Children and Adolescents","volume":"101","author":"Attarbaschi","year":"2016","journal-title":"Haematologica"},{"key":"B14","article-title":"Development of Cancer in Patients With Primary Immunodeficiencies","volume":"28","author":"Salavoura","year":"2008","journal-title":"Anticancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.384","article-title":"Spectrum of Myeloid Neoplasms and Immune Deficiency Associated With Germline GATA2 Mutations","volume":"4","author":"Mir","year":"2015","journal-title":"Cancer Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30826","article-title":"A Consensus Review on Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adults","volume":"123","author":"Daver","year":"2017","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6898","article-title":"Germline Cytotoxic Lymphocytes Defective Mutations in Chinese Patients With Lymphoma","volume":"14","author":"Chen","year":"2017","journal-title":"Oncol Lett"},{"key":"B18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jaci.2015.02.022","article-title":"Novel Mutations in TNFRSF7\/CD27: Clinical, Immunologic, and Genetic Characterization of Human CD27 Deficiency","volume":"136","author":"Alkhairy","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20160849","article-title":"Combined Immunodeficiency and Epstein-Barr Virus-Induced B Cell Malignancy in Humans With Inherited CD70 Deficiency","volume":"214","author":"Abolhassani","year":"2017","journal-title":"J Exp Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161846","article-title":"Human Immunity Against EBV-Lessons From the Clinic","volume":"214","author":"Tangye","year":"2017","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130592","article-title":"Inherited Human OX40 Deficiency Underlying Classic Kaposi Sarcoma of Childhood","volume":"210","author":"Byun","year":"2013","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-538686","article-title":"XMEN Disease: A New Primary Immunodeficiency Affecting Mg2+ Regulation of Immunity Against Epstein-Barr Virus","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1406","article-title":"Epstein-Barr Virus LMP1 Inhibits the Expression of SAP Gene and Upregulates Th1 Cytokines in the Pathogenesis of Hemophagocytic Syndrome","volume":"106","author":"Chuang","year":"2005","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nature13386","article-title":"CTP Synthase 1 Deficiency in Humans Reveals its Central Role in Lymphocyte Proliferation","volume":"510","author":"Martin","year":"2014","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.08.007","article-title":"Combined Immunodeficiency With EBV Positive B Cell Lymphoma and Epidermodysplasia Verruciformis Due to a Novel Homozygous Mutation in RASGRP1","volume":"183","author":"Platt","year":"2017","journal-title":"Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14304\/SURYA.JPR.V2N6.1","article-title":"Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) in T-Cell Related Diseases","volume":"2","author":"Zhong","year":"2014","journal-title":"Postdoc J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-018-0012-x","article-title":"Clinical Implications of Systematic Phenotyping and Exome Sequencing in Patients With Primary Antibody Deficiency","volume":"21","author":"Abolhassani","year":"2019","journal-title":"Genet Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000929","article-title":"Current Genetic Landscape in Common Variable Immune Deficiency","volume":"35","author":"Abolhassani","year":"2020","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1749-6632.2011.06322.x","article-title":"DNA Repair: The Link Between Primary Immunodeficiency and Cancer","volume":"1246","author":"de Miranda","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16774","article-title":"Partial T and B Lymphocyte Immunodeficiency and Predisposition to Lymphoma in Patients With Hypomorphic Mutations in Artemis","volume":"111","author":"Moshous","year":"2003","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nri2941","article-title":"Recombination Centres and the Orchestration of V(D)J Recombination","volume":"11","author":"Schatz","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/v9110341","article-title":"Epstein-Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle","volume":"9","author":"Hau","year":"2017","journal-title":"Viruses"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1038\/onc.2009.258","article-title":"Three Epstein-Barr Virus Latency Proteins Independently Promote Genomic Instability by Inducing DNA Damage, Inhibiting DNA Repair and Inactivating Cell Cycle Checkpoints","volume":"28","author":"Gruhne","year":"2009","journal-title":"Oncogene"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14339","article-title":"Severe Epstein-Barr Virus Infection in Primary Immunodeficiency and the Normal Host","volume":"175","author":"Worth","year":"2016","journal-title":"Br J Haematol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2016.05.032","article-title":"EBV-LMP1 Suppresses the DNA Damage Response Through DNA-PK\/AMPK Signaling to Promote Radioresistance in Nasopharyngeal Carcinoma","volume":"380","author":"Lu","year":"2016","journal-title":"Cancer Lett"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1313.119","article-title":"DNA Lesions and Repair in Immunoglobulin Class Switch Recombination and Somatic Hypermutation","volume":"1050","author":"Xu","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1017\/S1462399410001419","article-title":"Primary Immunodeficiencies Associated With DNA-Repair Disorders","volume":"12","author":"Slatter","year":"2010","journal-title":"Expert Rev Mol Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2007.35","article-title":"AID Is Required for Germinal Center-Derived Lymphomagenesis","volume":"40","author":"Pasqualucci","year":"2008","journal-title":"Nat Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/ar3904","article-title":"Immunoglobulin Class-Switch Recombination Deficiencies","volume":"14","author":"Durandy","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2014.03.014","article-title":"DNA Double-Strand Break Repair Pathway Choice and Cancer","volume":"19","author":"Aparicio","year":"2014","journal-title":"DNA Repair (Amst)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/hmg\/ddm341","article-title":"DNA Methyltransferase 3B (DNMT3B) Mutations in ICF Syndrome Lead to Altered Epigenetic Modifications and Aberrant Expression of Genes Regulating Development, Neurogenesis and Immune Function","volume":"17","author":"Jin","year":"2008","journal-title":"Hum Mol Genet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19980911)77:6<833::aid-ijc6>3.0.co;2-v","article-title":"Hypomethylation of Pericentromeric DNA in Breast Adenocarcinomas","volume":"77","author":"Narayan","year":"1998","journal-title":"Int J Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2013.40","article-title":"Heterogeneous Clinical Presentation in ICF Syndrome: Correlation With Underlying Gene Defects","volume":"21","author":"Weemaes","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.jaip.2018.09.004","article-title":"Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort","volume":"7","author":"Yazdani","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666200613204426","article-title":"Clinical, Immunologic and Molecular Spectrum of Patients With Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome: A Systematic Review","volume":"21","author":"Kiaee","year":"2021","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-3198","article-title":"Are Short Telomeres Hallmarks of Cancer Recurrence","volume":"20","author":"Shay","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.1016\/S1016-8478(23)13723-X","article-title":"Telomeres and Telomerase in Aging, Regeneration and Cancer","volume":"15","author":"Djojosubroto","year":"2003","journal-title":"Mol Cells"},{"key":"B48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/genes7070038","article-title":"Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications","volume":"7","author":"Liu","year":"2016","journal-title":"Genes (Basel)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86042","article-title":"Telomerase Reverse Transcriptase Promotes Cancer Cell Proliferation by Augmenting tRNA Expression","volume":"126","author":"Khattar","year":"2016","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-153445","article-title":"TINF2 Mutations Result in Very Short Telomeres: Analysis of a Large Cohort of Patients With Dyskeratosis Congenita and Related Bone Marrow Failure Syndromes","volume":"112","author":"Walne","year":"2008","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1182\/blood-2012-03-418038","article-title":"Conditional TRF1 Knockout in the Hematopoietic Compartment Leads to Bone Marrow Failure and Recapitulates Clinical Features of Dyskeratosis Congenita","volume":"120","author":"Beier","year":"2012","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12317","article-title":"Expanding the Clinical Phenotype of Autosomal Dominant Dyskeratosis Congenita Caused by TERT Mutations","volume":"93","author":"Basel-Vanagaite","year":"2008","journal-title":"Haematologica"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-43552","article-title":"Coats\u2019 Plus: A Progressive Familial Syndrome of Bilateral Coats\u2019 Disease, Characteristic Cerebral Calcification, Leukoencephalopathy, Slow Pre- and Post-Natal Linear Growth and Defects of Bone Marrow and Integument","volume":"35","author":"Crow","year":"2004","journal-title":"Neuropediatrics"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24193","article-title":"CTC1 Mutations in a Patient With Dyskeratosis Congenita","volume":"59","author":"Keller","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.11.052","article-title":"Common Variable Immunodeficiency as the Initial Presentation of Dyskeratosis Congenita","volume":"132","author":"Allenspach","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.12.006","article-title":"Primary Immunodeficiencies and Inflammatory Disease: A Growing Genetic Intersection","volume":"37","author":"Fodil","year":"2016","journal-title":"Trends Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-immunol-051116-052442","article-title":"Genetics of Infectious and Inflammatory Diseases: Overlapping Discoveries From Association and Exome-Sequencing Studies","volume":"35","author":"Langlais","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000532","article-title":"Large B-Cell Lymphoma in an Adolescent Patient With Interleukin-10 Receptor Deficiency and History of Infantile Inflammatory Bowel Disease","volume":"63","author":"Shouval","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110958","article-title":"Gain-Of-Function Human STAT1 Mutations Impair IL-17 Immunity and Underlie Chronic Mucocutaneous Candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/13693780701616023","article-title":"Chronic Mucocutaneous Candidiasis and Oesophageal Cancer","volume":"46","author":"Rosa","year":"2008","journal-title":"Med Mycol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-8996-5","article-title":"Global Report on Primary Immunodeficiencies: 2018 Update From the Jeffrey Modell Centers Network on Disease Classification, Regional Trends, Treatment Modalities, and Physician Reported Outcomes","volume":"66","author":"Modell","year":"2018","journal-title":"Immunol Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0124-2","article-title":"IgA Deficiency and Risk of Cancer: A Population-Based Matched Cohort Study","volume":"35","author":"Ludvigsson","year":"2015","journal-title":"J Clin Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2017.01.006","article-title":"Epidemiology and Pathophysiology of Malignancy in Common Variable Immunodeficiency","volume":"45","author":"Tak Manesh","year":"2017","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-272351","article-title":"Are Antibody Deficiency Disorders Associated With a Narrower Range of Cancers Than Other Forms of Immunodeficiency","volume":"116","author":"Vajdic","year":"2010","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04384.x","article-title":"Review of Gastric Cancer Risk Factors in Patients With Common Variable Immunodeficiency Disorders, Resulting in a Proposal for a Surveillance Programme","volume":"165","author":"Dhalla","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","article-title":"Cancer Risk Among Patients With IgA Deficiency or Common Variable Immunodeficiency and Their Relatives: A Combined Danish and Swedish Study","volume":"130","author":"Mellemkjaer","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B67","unstructured":"Hernandez-TrujilloV 2021"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0132-x","article-title":"Are Patients With X-Linked Agammaglobulinemia at Increased Risk of Developing Acute Lymphoblastic Leukemia","volume":"35","author":"Conley","year":"2015","journal-title":"J Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01050-2","article-title":"Decreased ATM Function Causes Delayed DNA Repair and Apoptosis in Common Variable Immunodeficiency Disorders","volume":"41","author":"Hargreaves","year":"2021","journal-title":"J Clin Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2018.77385","article-title":"In Vitro Chromosomal Radiosensitivity in Patients With Common Variable Immunodeficiency","volume":"43","author":"Mahmoodi","year":"2018","journal-title":"Cent Eur J Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12026-007-8001-1","article-title":"The Autoimmune Lymphoproliferative Syndrome: An Experiment of Nature Involving Lymphocyte Apoptosis","volume":"40","author":"Fleisher","year":"2008","journal-title":"Immunol Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.9.5.1031","article-title":"Targeting the Fas\/Fas Ligand Pathway in Cancer","volume":"9","author":"O\u2019Brien","year":"2005","journal-title":"Expert Opin Ther Targets"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.12688\/f1000research.11545.1","article-title":"Autoimmune Lymphoproliferative Syndrome: More Than a FAScinating Disease","volume":"6","author":"Bride","year":"2017","journal-title":"F1000Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3758","article-title":"Activation of the Fas-FasL Signaling Pathway by MDA-7\/IL-24 Kills Human Ovarian Cancer Cells","volume":"65","author":"Gopalan","year":"2005","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.9.3018","article-title":"Somatic Fas Mutations in Non-Hodgkin\u2019s Lymphoma: Association With Extranodal Disease and Autoimmunity","volume":"92","author":"Gronbaek","year":"1998","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1471-4906(01)02115-9","article-title":"The Origin of CD95-Gene Mutations in B-Cell Lymphoma","volume":"23","author":"Muschen","year":"2002","journal-title":"Trends Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737462","article-title":"How Apoptosis Got the Immune System in Shape","author":"Feig","year":"2007","journal-title":"Eur J Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.2174\/1871530317666170919120245","article-title":"Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (CVID)","volume":"17","author":"Ganjalikhani-Hakemi","year":"2017","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2015.12.016","article-title":"Role of Apoptosis in Common Variable Immunodeficiency and Selective Immunoglobulin A Deficiency","volume":"71","author":"Yazdani","year":"2016","journal-title":"Mol Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.02.005","article-title":"Deregulation of Cell Signaling in Cancer","volume":"588","author":"Giancotti","year":"2014","journal-title":"FEBS Lett"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2016.00172","article-title":"Bone Marrow Immunity and Myelodysplasia","volume":"6","author":"Lambert","year":"2016","journal-title":"Front Oncol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/ACI.0000000000000014","article-title":"Pathogenic Mechanisms and Clinical Implications of Congenital Neutropenia Syndromes","volume":"13","author":"Hauck","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000206","article-title":"Signal Transducer and Activator of Transcription 3: A Year in Review","volume":"23","author":"Forbes","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4161\/jkst.20045","article-title":"STAT1 and STAT3 in Tumorigenesis: A Matter of Balance","volume":"1","author":"Avalle","year":"2012","journal-title":"JAKSTAT"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000217","article-title":"Gain-Of-Function Mutations and Immunodeficiency: At a Loss for Proper Tuning of Lymphocyte Signaling","volume":"15","author":"Arjunaraja","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01132","article-title":"Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development","volume":"8","author":"Kantono","year":"2017","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00543","article-title":"Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase Delta Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase Delta Syndrome Registry","volume":"9","author":"Maccari","year":"2018","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical Spectrum and Features of Activated Phosphoinositide 3-Kinase Delta Syndrome: A Large Patient Cohort Study","volume":"139","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ccr.2014.07.027","article-title":"Cancer-Selective Targeting of the NF-kappaB Survival Pathway With GADD45beta\/MKK7 Inhibitors","volume":"26","author":"Tornatore","year":"2014","journal-title":"Cancer Cell"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2015.3","article-title":"Rare Mendelian Primary Immunodeficiency Diseases Associated With Impaired NF-kappaB Signaling","volume":"16","author":"Paciolla","year":"2015","journal-title":"Genes Immun"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"Loss-Of-Function Nuclear Factor kappaB Subunit 1 (NFKB1) Variants are the Most Common Monogenic Cause of Common Variable Immunodeficiency in Europeans","volume":"142","author":"Tuijnenburg","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1608448114","article-title":"NFkappaB-Pim-1-Eomesodermin Axis Is Critical for Maintaining CD8 T-Cell Memory Quality","volume":"114","author":"Knudson","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0310-5","article-title":"The Expanding Spectrum of NFkB1 Deficiency","volume":"36","author":"Bryant","year":"2016","journal-title":"J Clin Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2013.07.006","article-title":"Evading Apoptosis in Cancer","volume":"23","author":"Fernald","year":"2013","journal-title":"Trends Cell Biol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402182","article-title":"Apoptosis in the Development of the Immune System","volume":"15","author":"Opferman","year":"2008","journal-title":"Cell Death Differ"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2004.02.001","article-title":"Transcriptional Control of the Core Cell-Death Machinery","volume":"29","author":"Kumar","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0015-0","article-title":"The Functions and Regulation of the PTEN Tumour Suppressor: New Modes and Prospects","volume":"19","author":"Lee","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.jaci.2016.07.010","article-title":"Increased PI3K\/Akt Activity and Deregulated Humoral Immune Response in Human PTEN Deficiency","volume":"138","author":"Driessen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1392856","article-title":"Ataxia Telangiectasia Syndrome: Moonlighting ATM","volume":"13","author":"Zaki-Dizaji","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clim.2017.06.003","article-title":"DOCK8 Deficiency: Insights Into Pathophysiology, Clinical Features and Management","volume":"181","author":"Biggs","year":"2017","journal-title":"Clin Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3746","article-title":"Autosomal Dominant Immune Dysregulation Syndrome in Humans With CTLA4 Mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients With LRBA Deficiency Show CTLA4 Loss and Immune Dysregulation Responsive to Abatacept Therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"B105","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10875-015-0224-7","article-title":"Spectrum of Phenotypes Associated With Mutations in LRBA","volume":"36","author":"Alkhairy","year":"2016","journal-title":"J Clin Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.10.025","article-title":"Defects in Plasma Cell Differentiation Are Associated With Primary Immunodeficiency in Human Subjects","volume":"141","author":"Pan-Hammarstrom","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0367-1","article-title":"Increased Incidence of Fatigue in Patients With Primary Immunodeficiency Disorders: Prevalence and Associations Within the US Immunodeficiency Network Registry","volume":"37","author":"Hajjar","year":"2017","journal-title":"J Clin Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00037","article-title":"The ATM Signaling Network in Development and Disease","volume":"4","author":"Stracker","year":"2013","journal-title":"Front Genet"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.10.008","article-title":"DNA Damage Response and Metabolic Disease","volume":"20","author":"Shimizu","year":"2014","journal-title":"Cell Metab"},{"key":"B110","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cell.2005.01.028","article-title":"DNA Repair, Genome Stability, and Aging","volume":"120","author":"Lombard","year":"2005","journal-title":"Cell"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-018-1142-y","article-title":"Inflammation, a Significant Player of Ataxia-Telangiectasia Pathogenesis","volume":"67","author":"Zaki-Dizaji","year":"2018","journal-title":"Inflammation Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.2006.2.3.213","article-title":"Angiogenesis in Cancer","volume":"2","author":"Nishida","year":"2006","journal-title":"Vasc Health Risk Manag"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0163-3","article-title":"Somatic Mosaicism for a NRAS Mutation Associates With Disparate Clinical Features in RAS-Associated Leukoproliferative Disease: A Report of Two Cases","volume":"35","author":"Shiota","year":"2015","journal-title":"J Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-567917","article-title":"JMML and RALD (Ras-Associated Autoimmune Leukoproliferative Disorder): Common Genetic Etiology Yet Clinically Distinct Entities","volume":"125","author":"Calvo","year":"2015","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M108069200","article-title":"Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation","volume":"276","author":"Meadows","year":"2001","journal-title":"J Biol Chem"},{"key":"B116","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbcan.2003.09.004","article-title":"Stimulation of Angiogenesis by Ras Proteins","volume":"1654","author":"Kranenburg","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00069","article-title":"The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling","volume":"4","author":"Stockmann","year":"2014","journal-title":"Front Oncol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-007-9074-0","article-title":"Angiogenesis and Chronic Inflammation: Cause or Consequence","volume":"10","author":"Costa","year":"2007","journal-title":"Angiogenesis"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00527","article-title":"Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy","volume":"9","author":"Albini","year":"2018","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jaci.2011.02.047","article-title":"Primary Immunodeficiency Diseases Associated With Increased Susceptibility to Viral Infections and Malignancies","volume":"127","author":"Rezaei","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-004-0135-6","article-title":"Novel Mutations of EVER1\/TMC6 Gene in a Japanese Patient With Epidermodysplasia Verruciformis","volume":"49","author":"Tate","year":"2004","journal-title":"J Hum Genet"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12927","article-title":"Primary Cutaneous Follicle Center Lymphoma in a Patient With WHIM Syndrome","volume":"30","author":"Yoshii","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.virol.2009.05.036","article-title":"HPV16 E7 Oncogene Expression in Normal Human Epithelial Cells Causes Molecular Changes Indicative of an Epithelial to Mesenchymal Transition","volume":"391","author":"Hellner","year":"2009","journal-title":"Virology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/s0042-6822(03)00390-8","article-title":"Microarray Analysis Identifies Differentiation-Associated Genes Regulated by Human Papillomavirus Type 16 E6","volume":"314","author":"Duffy","year":"2003","journal-title":"Virology"},{"key":"B125","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.74.19.9115-9124.2000","article-title":"The LMP2A ITAM is Essential for Providing B Cells With Development and Survival Signals In Vivo","volume":"74","author":"Merchant","year":"2000","journal-title":"J Virol"},{"key":"B126","article-title":"Revisiting the Hallmarks of Cancer","volume":"7","author":"Fouad","year":"2017","journal-title":"Am J Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.720025\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T13:35:04Z","timestamp":1725629704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.720025\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":126,"alternative-id":["10.3389\/fimmu.2021.720025"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.720025","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"article-number":"720025"}}